Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Rigel Pharmaceuticals
Business Segments
Products & Services
Deferred Revenue
Deferred Revenue
Rigel Pharmaceuticals
·
Products & Services
·
2 segments
·
Rolls up to
Contract Liabilities
Breakdown
Segments
ocadusertib
View metric
fostamatinib
View metric
Quarterly
Annual
TTM
Segment
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
fostamatinib
$1.4M
$1.4M
$1.4M
$3M
$1.4M
$1.4M
$1.4M
$1.4M
ocadusertib
$0
$0
$0
$0
$0
$0
$0
$0
Total
—
—
—
—
—
—
—
—